Alba-Roth J, Müller O A, Schopohl J, von Werder K
Medizinische Klinik Innenstadt, University of Munich, West Germany.
J Clin Endocrinol Metab. 1988 Dec;67(6):1186-9. doi: 10.1210/jcem-67-6-1186.
To determine how arginine (Arg) stimulates GH secretion, we investigated its interaction with GHRH in vivo and in vitro. Six normal men were studied on four occasions: 1) Arg-TRH, 30 g arginine were administered in 500 mL saline in 30 min, followed by an injection of 200 micrograms TRH; 2) GHRH-Arg-TRH, 100 micrograms GHRH-(1-44) were given iv as a bolus immediately before the Arg infusion, followed by 200 micrograms TRH, iv; 3) GHRH test, 100 micrograms GHRH were given as an iv bolus; and 4) TRH test, 200 micrograms TRH were given iv as a bolus dose. Blood samples were collected at 15-min intervals for 30 min before and 120 min after the start of each infusion. Anterior pituitary cells from rats were coincubated with Arg (3, 6, 15, 30, and 60 mg/mL) and GHRH (0.05, 1, 5, and 10 nmol/L) for a period of 3 h. Rat GH was measured in the medium. After Arg-TRH the mean serum GH concentration increased significantly from 0.6 to 23.3 +/- 7.3 (+/- SE) micrograms/L at 60 min. TRH increased serum TSH and PRL significantly (maximum TSH, 11.1 +/- 1.8 mU/L; maximum PRL, 74.6 +/- 8.4 micrograms/L). After GHRH-Arg-TRH, the maximal serum GH level was significantly higher (72.7 +/- 13.4 micrograms/L) than that after Arg-TRH alone, whereas serum TSH and PRL increased to comparable levels (TSH, 10.2 +/- 3.0 mU/L; PRL, 64.4 +/- 13.6 micrograms/L). GHRH alone increased serum GH to 44.9 +/- 9.8 micrograms/L, significantly less than when GHRH, Arg, and TRH were given. TRH alone increased serum TSH to 6.6 +/- 0.6 mU/L, significantly less than the TSH response to Arg-TRH. The PRL increase after TRH only also was lower (47.2 +/- 6.8 micrograms/L) than the PRL response after Arg-TRH. In vitro Arg had no effect on basal and GHRH-stimulated GH secretion. Our results indicate that Arg administered with GHRH led to higher serum GH levels than did a maximally stimulatory dose of GHRH or Arg alone. The serum TSH response to Arg-TRH also was greater than that to TRH alone. We conclude that the stimulatory effects of Arg are mediated by suppression of endogenous somatostatin secretion.
为了确定精氨酸(Arg)如何刺激生长激素(GH)分泌,我们在体内和体外研究了其与生长激素释放激素(GHRH)的相互作用。对6名正常男性进行了4次研究:1)精氨酸 - 促甲状腺激素释放激素(Arg - TRH),在30分钟内将30克精氨酸溶于500毫升生理盐水中给药,随后注射200微克促甲状腺激素释放激素(TRH);2)生长激素释放激素 - 精氨酸 - 促甲状腺激素释放激素(GHRH - Arg - TRH),在精氨酸输注前立即静脉推注100微克生长激素释放激素(1 - 44),随后静脉注射200微克促甲状腺激素释放激素(TRH);3)生长激素释放激素试验,静脉推注100微克生长激素释放激素;4)促甲状腺激素释放激素试验,静脉推注200微克促甲状腺激素释放激素。在每次输注开始前30分钟和开始后120分钟,每隔15分钟采集血样。将大鼠垂体前叶细胞与精氨酸(3、6、15、30和60毫克/毫升)和生长激素释放激素(0.05、1、5和10纳摩尔/升)共同孵育3小时。测定培养基中的大鼠生长激素。精氨酸 - 促甲状腺激素释放激素给药后,60分钟时血清生长激素平均浓度从0.6显著增加至23.3±7.3(±标准误)微克/升。促甲状腺激素释放激素显著增加血清促甲状腺激素(TSH)和催乳素(PRL)水平(最大TSH,11.1±1.8毫国际单位/升;最大PRL,74.6±8.4微克/升)。生长激素释放激素 - 精氨酸 - 促甲状腺激素释放激素给药后,血清生长激素最大水平显著高于单独使用精氨酸 - 促甲状腺激素释放激素后的水平(分别为72.7±13.4微克/升),而血清促甲状腺激素和催乳素增加到相当水平(TSH,10.2±3.0毫国际单位/升;PRL,64.4±13.6微克/升)。单独使用生长激素释放激素使血清生长激素增加到44.9±9.8微克/升,显著低于同时给予生长激素释放激素、精氨酸和促甲状腺激素释放激素时的水平。单独使用促甲状腺激素释放激素使血清促甲状腺激素增加到6.6±0.6毫国际单位/升,显著低于促甲状腺激素释放激素对精氨酸 - 促甲状腺激素释放激素的反应。单独使用促甲状腺激素释放激素后催乳素的增加也低于精氨酸 - 促甲状腺激素释放激素后的催乳素反应(47.2±6.8微克/升)。在体外,精氨酸对基础和生长激素释放激素刺激的生长激素分泌无影响。我们的结果表明,与生长激素释放激素一起给予精氨酸导致的血清生长激素水平高于单独使用最大刺激剂量的生长激素释放激素或精氨酸时的水平。精氨酸 - 促甲状腺激素释放激素引起的血清促甲状腺激素反应也大于单独使用促甲状腺激素释放激素时的反应。我们得出结论,精氨酸的刺激作用是通过抑制内源性生长抑素分泌介导的。